Search Results 11-20 of 17898 for Metaplasia
... metaplasia, dysplasia, or EAC versus patients who achieved complete remission for at least > 1 year following initial endoscopic intervention, and to ...
... metaplasia. BE , which can progress to dysplasia, is a known risk factor for esophageal adenocarcinoma. A handful of older, smaller studies examining BE in ...
Treatment with RFA and resection can reduce the risk of cancer progression and induce complete remission of intestinal metaplasia (CRIM), both endoscopically ...
... metaplasia following endoscopic ablation. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...
Recurrence of intestinal metaplasia and dysplasia after complete endoscopic eradication therapy (EET) of dysplasia or early adenocarcinoma is well documented.
Find out more about this bone marrow cancer. Learn about symptoms, diagnosis and treatments for primary myelofibrosis and secondary myelofibrosis.
... metaplasia. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns ...
About this study. The aim of the clinical trial is evaluate the EndoRotor®'s ability to completely remove areas of Barrett's metaplasia considered ...
In the presence of an oncogenic KRAS mutation, cells that have undergone acinar-to-ductal metaplasia progress to pancreatic intraepithelial neoplasia and ...
... metaplasia (IM) in the tubular esophagus after 3 or more radiofrequency ablations (RFA) for dysplastic BE, or <50% eradication of Barrett's Esophagus (BE) ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.